Article
Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency.
Pituitary - 1 Feb 2015
Andujar-Plata P, Fernandez-Rodriguez E, Quinteiro C, Casanueva F F, Bernabeu I
Abstract excerpt
PURPOSE: The treatment of adults with GH deficiency (GHD) with human recombinant growth hormone has interindividual variability and several factors influence it. The aims of this study were : 1-to analyze the GH receptor (GHR) genotype in terms of exon 3 deletion GHR (d3-GHR) in adults with GHD; 2-to assess the effects of d3-GHR on initial IGF-I levels; 3-to evaluate whether d3-GHR and/or initial IGF-I levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
